September 14, 2016 — A backyard gardener who blames his diagnosis of cancer on the weed-killer Roundup has filed a lawsuit against Monsanto.
The plaintiff is Anthony Harris, a man who used Roundup “extensively” on his property in San Diego, California between 2008 and 2010.
In January 2015, he was diagnosed with non-Hodgkin lymphoma. His treatments include over 20 rounds of chemotherapy and stem cells. According to the lawsuit (PDF):
“Roundup and/or glyphosate is defective, dangerous to human health, unfit and unsuitable to be marketed and sold in commerce, and lacked proper warnings and directions as to the dangers associated with its use.”
Dozens of similar lawsuits have been filed by farmworkers, landscapers, and farmers. However, a growing number of lawsuits involve home gardeners. One was recently filed by a woman who used a backpack to spray Roundup on her one-acre property.
The litigation has grown steadily since the International Agency for Research on Cancer (IARC) re-classified glyphosate as a “probable human carcinogen.” The agency based its conclusions on a number of studies around the world linking glyphosate exposure with non-Hodgkin lymphoma, including one study that found a 60% increased risk among American farmworkers.
The lawsuit was filed in the U.S. District Court for the Southern District of California — Case No. 3:16-cv-02275.
Do I have a Roundup Lawsuit?
The Schmidt Firm, PLLC is currently accepting Roundup induced injury cases in all 50 states. If you or somebody you know has been diagnosed with non-Hodgkin lymphoma, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Toxic Chemical Exposure Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.